Locatelli, Franco <br/><br/>
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia  09 2020 
 - 2473-2478 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/s41375-020-0770-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Bispecific--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Male<br/>Philadelphia Chromosome<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Recurrence